心脏骤停后院前最佳血压水平是什么?一项关于血管活性药物治疗患者血压与死亡率相关性的回顾性队列研究
该回顾性登记队列研究纳入2012年1月1日至2019年8月31日期间由直升机紧急医疗服务(HEMS)医生参与复苏后救治并使用血管活性药物的心脏骤停患者。按交接至医院时收缩压分为<100、100-119、120-140、>140 mmHg四组,采用多因素logistic回归控制年龄、性别、自主循环恢复时间、推测心脏病因、目击骤停、初始心律及旁观者心肺复苏,评估30天和1天死亡率。共3029例复苏后病例由HEMS接诊,其中1861例接受血管活性药物,1665例变量完整纳入主要分析。与低血压组(收缩压<100 mmHg)相比,收缩压100-119、120-140和>140 mmHg组的30天死亡比值比分别为0.54(0.37-0.80)、0.58(0.40-0.85)和0.78(0.51-1.18);1天死亡比值比分别为0.42(0.28-0.61)、0.42(0.29-0.61)和0.36(0.23-0.55)。作者认为正常血压(收缩压100-140 mmHg)与较低死亡率相关,可作为未来前瞻性试验的基础。
要点
- 院前复苏后使用血管活性药物的心脏骤停患者中,交接时收缩压100-119 mmHg组30天死亡比值比为0.54(0.37-0.80),低于收缩压<100 mmHg组。
- 收缩压120-140 mmHg组30天死亡比值比为0.58(0.40-0.85),亦低于收缩压<100 mmHg组。
- 收缩压>140 mmHg组30天死亡比值比为0.78(0.51-1.18),与收缩压<100 mmHg组相比未达统计学显著。
- 1天死亡比值比在收缩压100-119、120-140和>140 mmHg组分别为0.42(0.28-0.61)、0.42(0.29-0.61)和0.36(0.23-0.55)。
- 作者认为正常血压(收缩压100-140 mmHg)与较低死亡率相关,可作为未来前瞻性试验的基础。
适用人群与场景
- 2012年1月1日至2019年8月31日期间由HEMS医生参与院前复苏后救治并使用血管活性药物的心脏骤停患者。
- 主要分析纳入1665例交接至医院时收缩压等必要变量记录完整的患者。
诊断标准与关键阈值
- 按交接至医院时收缩压分为四组:<100 mmHg、100-119 mmHg、120-140 mmHg、>140 mmHg。
研究设计与关键结果
- 回顾性登记队列研究,共3029例复苏后病例由HEMS接诊,其中1861例接受血管活性药物,1665例变量完整纳入主要分析。
- 与收缩压<100 mmHg组相比,30天死亡比值比在100-119 mmHg组为0.54(0.37-0.80)、120-140 mmHg组为0.58(0.40-0.85)、>140 mmHg组为0.78(0.51-1.18)。
- 与收缩压<100 mmHg组相比,1天死亡比值比在100-119 mmHg组为0.42(0.28-0.61)、120-140 mmHg组为0.42(0.29-0.61)、>140 mmHg组为0.36(0.23-0.55)。
- 多因素logistic回归控制年龄、性别、自主循环恢复时间、推测心脏病因、目击骤停、初始心律及旁观者心肺复苏。
证据类型、等级与局限
- 证据类型:回顾性登记队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为正常血压(收缩压100-140 mmHg)与较低死亡率相关,可作为未来前瞻性试验的基础。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Vasoactive drugs are often initiated during prehospital post-resuscitation care by Helicopter Emergency Medical Services (HEMS). Evidence is limited regarding treatment targets to ensure optimised survival. Hence, guidelines remain vague. We aimed to compare 30-day and 1-day mortality based on systolic blood pressure (SBP) attained after the administration of vasoactive medication during prehospital post-resuscitation care.
METHODS: We conducted a retrospective registry-based cohort study including post-resuscitation care cases attended by a HEMS-physician in which vasoactive treatment was used between 1.1.2012 and 31.8.2019. Patients were categorised according to SBP at handover to hospital: <100, 100-119, 120-140, >140 mmHg. Multivariate logistic regression was used to assess 30- and 1-day mortality, while controlling for age, sex, time to return of spontaneous circulation, presumed cardiac aetiology for arrest, whether the arrest was witnessed, initial rhythm and presence of bystander cardiopulmonary resuscitation.
RESULTS: 3029 post-resuscitation cases were attended by HEMS. In these cases, a total of 1861 patients received vasoactive medication. 1665 patients had necessary variables recorded and were included in our primary analysis. Compared to hypotensive (SBP < 100 mmHg), odds ratios for 30-day mortalities were 0.54 (0.37-0.80), 0.58 (0.40 - 0.85), and 0.78 (0.51-1.18) in respective SBP categories of 100-119, 120-140 and > 140 mmHg. Furthermore, odds ratios for 1-day mortalities were 0.42 (0.28-0.61), 0.42 (0.29-0.61), and 0.36 (0.23-0.55), respectively.
CONCLUSIONS: Normotension (SBP 100-140 mmHg) was associated with lower mortality compared to hypo- and hypertensive patients. This can be considered a basis for future prospective trials.
参考来源
- Niiranen A, Saviluoto A, Kirves H, et al. What is the optimal prehospital blood pressure level after cardiac arrest? A retrospective cohort study on the association of blood pressure and mortality among patients treated with vasoactive medication. Resuscitation. 2025. PMID: 40113009. doi:10.1016/j.resuscitation.2025.110589
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。